Edifice Health is a company that develops systemic chronic inflammation (SCI) tests designed to improve inflammatory and immune health measuring methods. Its tests predict the onset of multiple chronic diseases, enabling patients to reach optimal immune health. The company aims to create a large longitudinal data and content set in immune health and age-related diseases for the discovery of interventions.
|Employees (est.) (Aug 2022)||16|
Edifice Health total Funding
Edifice Health latest funding size
Time since last funding
|a year ago|
Edifice Health investors
|Paladin Capital Group, Alafi Capital, Vertical Venture Partners, Better Food Ventures, Leaps by Bayer, Ahren Innovation Capital, Taisho Pharmaceutical, Ataraxia Capital Partners, Shanda Grab Ventures, Human Longevity and Performance Impact Venture Fund, Longevity Incubator Fund, Summer Venture Capital, Carlyle Global Advisors, M4 Capital GmbH|
Edifice Health has 94 Twitter Followers. The number of followers has increased 3.1% month over month and increased 17.9% quarter over quarter
When was Edifice Health founded?
Edifice Health was founded in 2018.
Who are Edifice Health key executives?
Edifice Health's key executives are Wolfgang Daum, Bryan Cox and Nina Richman.
How many employees does Edifice Health have?
Edifice Health has 16 employees.
Who are Edifice Health competitors?
Competitors of Edifice Health include Poplar Healthcare, Indus Hospitals and Iris Plans.
Receive alerts for 300+ data fields across thousands of companies